Literature DB >> 17962043

Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.

Hiroshi Ito1, Hidehiko Takahashi, Ryosuke Arakawa, Harumasa Takano, Tetsuya Suhara.   

Abstract

The central dopaminergic system is of interest in the pathophysiology of schizophrenia and other neuropsychiatric disorders. Both pre- and postsynaptic dopaminergic functions can be estimated by positron emission tomography (PET) with different radiotracers. However, an integrated database of both pre- and postsynaptic dopaminergic neurotransmission components including receptors, transporter, and endogenous neurotransmitter synthesis has not yet been reported. In the present study, we constructed a normal database for the pre- and postsynaptic dopaminergic functions in the living human brain using PET. To measure striatal and extrastriatal dopamine D(1) and D(2) receptor bindings, dopamine transporter binding, and endogenous dopamine synthesis rate, PET scans were performed on healthy men after intravenous injection of [(11)C]SCH23390, [(11)C]raclopride, [(11)C]FLB457, [(11)C]PE2I, or L-[beta-(11)C]DOPA. All PET images were anatomically standardized using SPM2, and a database was built for each radiotracer. Gray matter images were segmented and extracted from all anatomically standardized magnetic resonance images using SPM2, and they were used for partial volume correction. These databases allow the comparison of regional distributions of striatal and extrastriatal dopamine D(1) and D(2) receptors, dopamine transporter, and endogenous dopamine synthesis capability. These distributions were in good agreement with those from human postmortem studies. This database can be used in various researches to understand the physiology of dopaminergic functions in the living human brain. This database could also be used to investigate regional abnormalities of dopaminergic neurotransmission in neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962043     DOI: 10.1016/j.neuroimage.2007.09.011

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  29 in total

1.  Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.

Authors:  Keisuke Takahata; Hiroshi Ito; Harumasa Takano; Ryosuke Arakawa; Hironobu Fujiwara; Yasuyuki Kimura; Fumitoshi Kodaka; Takeshi Sasaki; Tsuyoshi Nogami; Masayuki Suzuki; Tomohisa Nagashima; Hitoshi Shimada; Motoichiro Kato; Masaru Mimura; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2012-01-12       Impact factor: 4.530

Review 2.  Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.

Authors:  Noble George; Emily G Gean; Ayon Nandi; Boris Frolov; Eram Zaidi; Ho Lee; James R Brašić; Dean F Wong
Journal:  CNS Drugs       Date:  2015-04       Impact factor: 5.749

3.  Modulative effects of COMT haplotype on age-related associations with brain morphology.

Authors:  Annie Lee; Anqi Qiu
Journal:  Hum Brain Mapp       Date:  2016-02-27       Impact factor: 5.038

4.  High long-term test-retest reliability for extrastriatal 11C-raclopride binding in healthy older adults.

Authors:  Nina Karalija; Lars Jonassson; Jarkko Johansson; Goran Papenberg; Alireza Salami; Micael Andersson; Katrine Riklund; Lars Nyberg; Carl-Johan Boraxbekk
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-10       Impact factor: 6.200

5.  Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.

Authors:  Mareike Clos; Nico Bunzeck; Tobias Sommer
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

6.  18F-fallypride binding potential in patients with schizophrenia compared to healthy controls.

Authors:  Douglas S Lehrer; Bradley T Christian; Cemil Kirbas; Meicheng Chiang; Shawn Sidhu; Holly Short; Binquan Wang; Bingzhi Shi; King-Wai Chu; Brian Merrill; Monte S Buchsbaum
Journal:  Schizophr Res       Date:  2010-07-23       Impact factor: 4.939

7.  Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography.

Authors:  Christine DeLorenzo; J S Dileep Kumar; Francesca Zanderigo; J John Mann; Ramin V Parsey
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-20       Impact factor: 6.200

8.  Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Authors:  Neil D Woodward; David H Zald; Zhaohua Ding; Patrizia Riccardi; M Sib Ansari; Ronald M Baldwin; Ronald L Cowan; Rui Li; Robert M Kessler
Journal:  Neuroimage       Date:  2009-02-05       Impact factor: 6.556

Review 9.  The dopaminergic basis of human behaviors: A review of molecular imaging studies.

Authors:  Alice Egerton; Mitul A Mehta; Andrew J Montgomery; Julia M Lappin; Oliver D Howes; Suzanne J Reeves; Vincent J Cunningham; Paul M Grasby
Journal:  Neurosci Biobehav Rev       Date:  2009-05-27       Impact factor: 8.989

10.  The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.

Authors:  Bradley T Christian; Nicholas T Vandehey; Andrew S Fox; Dhanabalan Murali; Terrence R Oakes; Alex K Converse; Robert J Nickles; Steve E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Neuroimage       Date:  2008-10-29       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.